NYSE · MFC
Manulife Financial Corporation
$45.25+$0.49 (+1.09%)
Manulife Financial Corporation’s quoted price sits in the upper half of its reported 52-week range, 0.94% below the high.
Loading market information…
NYSE · MET · USD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
MetLife, Inc.’s quoted price sits in the upper half of its reported 52-week range, 2.72% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
MetLife, Inc.’s forward annual dividend is $2.37 per share, paid quarterly. The forward yield is 2.35% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
MetLife, Inc.’s next earnings report is currently expected on Nov 4, 2026, with estimated earnings per share of $2.77. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow MetLife, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
MetLife, Inc. operates as a leading global financial services entity, delivering an extensive array of services encompassing insurance, annuities, employee benefits, and asset management. The company manages its operations through five primary divisions: the U.S., Asia, Latin America, Europe, the Middle East and Africa (EMEA), and MetLife Holdings. Its broad insurance offerings include life, dental, group short-term and long-term disability, individual disability, pet, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans. MetLife also supports employers with administrative services-only (ASO) arrangements. Furthermore, it provides sophisticated financial instruments such as general and separate account contracts, synthetic guaranteed interest contracts, and private floating rate funding agreements. The company facilitates pension risk transfers, offers institutional income annuities, structures settlements, and delivers capital markets investment products. Specialized life insurance products and funding agreements are also available for post-retirement benefits, alongside company, bank, or trust-owned life insurance used to finance non-qualified executive benefit programs. In addition, MetLife offers a variety of annuity options including fixed, indexed-linked, and variable, alongside pension and regular savings products. Its life insurance portfolio features whole life, term life, endowments, universal and variable life, and group life policies. The company also provides longevity reinsurance solutions, credit insurance products, and protection for long-term healthcare services. MetLife, Inc. was founded in 1863 and is headquartered in New York City.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:39 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q1 2025 |
|---|
| Apr 30, 2025 |
| $1.96-2.0% vs estimate |
| $18.28B-0.48% vs estimate |
| Q4 2024 | Feb 5, 2025 | $2.08-1.42% vs estimate | $18.38B-5.78% vs estimate |
|---|
| Q3 2024 | Oct 30, 2024 | $1.95-10.14% vs estimate | $18.44B-1.16% vs estimate |
|---|
THE ANALYST VIEW
33 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 8 contributors · Median target $109.50.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$45.25+$0.49 (+1.09%)
Manulife Financial Corporation’s quoted price sits in the upper half of its reported 52-week range, 0.94% below the high.
$123.54+$1.79 (+1.47%)
Aflac Incorporated’s quoted price sits in the upper half of its reported 52-week range, 5.13% below the high.
$116.87+$1.50 (+1.3%)
Prudential Financial, Inc.’s quoted price sits in the upper half of its reported 52-week range, 8.5% below the high.
$91.59+$1.34 (+1.48%)
Unum Group’s quoted price sits in the upper half of its reported 52-week range, 5.35% below the high.
$160.45+$2.08 (+1.31%)
Globe Life Inc.’s quoted price sits in the upper half of its reported 52-week range, 16.24% below the high.
$98.39+$1.83 (+1.9%)
Voya Financial, Inc.’s quoted price sits in the upper half of its reported 52-week range, 6.86% below the high.
$283.55+$4.49 (+1.61%)
Primerica, Inc.’s quoted price sits in the upper half of its reported 52-week range, 13.36% below the high.
$41.37+$0.71 (+1.75%)
Lincoln National Corporation’s quoted price sits in the upper half of its reported 52-week range, 13.22% below the high.
